Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Hunting (HTG) by Canaccord Genuity
- Buy System1 Group (SYS1) by Canaccord Genuity
- Buy Jet2 (JET2) by Canaccord Genuity
- Underweight Rightmove (RMV) by JP Morgan
- Neutral Victrex plc (VCT) by JP Morgan
- Overweight Convatec Group (CTEC) by JP Morgan
- Outperform Hays (HAS) by RBC Capital
- Hold Close Brothers Group (CBG) by Shore Capital
- Buy The Gym Group (GYM) by Shore Capital
- Neutral WPP (WPP) by JP Morgan
- Neutral Abrdn (ABDN) by Citi
- Buy Imperial Brands (IMB) by Simon Watkins in The Motley Fool
- Avoid 1Spatial (SPA) by Steve Moore in ShareProphets
- Buy Galliford Try (GFRD) by Berenberg
- Buy Impax Asset Management Group (IPX) by Berenberg
- Buy Coca-Cola Europacific Partners (DI) (CCEP) by Deutsche Bank
- Hold Diageo (DGE) by Deutsche Bank
- Buy London Stock Exchange Group (LSEG) by Deutsche Bank
- Buy CRH (CDI) (CRH) by UBS
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,220 open tips for AstraZeneca (AZN)
| Latest Bid : 10,248.00p | Latest Ask : 10,252.00p |
| High Today : 10,376.00p | Low Today : 10,244.00p |
| This Years High : 13,276.00p | This Years Low : 9,667.00p |
| Volume : 297,157 | MKT Cap : £158906M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2025-07-09 05:52:00 09/07/2025 | -0.21% |
| Hold | Deutsche Bank | Premium Only | 2025-07-08 13:16:00 08/07/2025 | 0.73% |
| Buy | Goldman Sachs | Premium Only | 2025-07-03 06:14:00 03/07/2025 | -1.40% |
| Buy | Simon Watkins | Premium Only | 2025-06-12 08:20:00 12/06/2025 | -6.45% |
| Buy | Goldman Sachs | Premium Only | 2025-05-28 05:52:00 28/05/2025 | -2.10% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10,248.00p | Latest Ask : 10,252.00p |
| High Today : 10,376.00p | Low Today : 10,244.00p |
| This Years High : 13,276.00p | This Years Low : 9,667.00p |
| Volume : 297,157 | MKT Cap : £158906M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2025-07-09 05:52:00 09/07/2025 | -0.21% |
| Hold | Deutsche Bank | Premium Only | 2025-07-08 13:16:00 08/07/2025 | 0.73% |
| Buy | Goldman Sachs | Premium Only | 2025-07-03 06:14:00 03/07/2025 | -1.40% |
| Buy | Simon Watkins | Premium Only | 2025-06-12 08:20:00 12/06/2025 | -6.45% |
| Buy | Goldman Sachs | Premium Only | 2025-05-28 05:52:00 28/05/2025 | -2.10% |